VivoSim Labs, Inc.
VIVS
$1.91
$0.0331.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 122.00K | 103.00K | 73.00K | 109.00K | 242.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 122.00K | 103.00K | 73.00K | 109.00K | 242.00K |
| Cost of Revenue | 5.23M | 4.89M | 5.24M | 5.50M | 9.88M |
| Gross Profit | -5.11M | -4.78M | -5.16M | -5.39M | -9.64M |
| SG&A Expenses | 7.45M | 7.99M | 9.11M | 9.70M | 10.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.68M | 12.87M | 14.35M | 15.20M | 20.01M |
| Operating Income | -12.56M | -12.77M | -14.28M | -15.09M | -19.77M |
| Income Before Tax | -12.38M | -12.54M | -13.99M | -14.67M | -19.08M |
| Income Tax Expenses | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K |
| Earnings from Continuing Operations | -12.39 | -12.54 | -13.99 | -14.67 | -19.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.39M | -12.54M | -13.99M | -14.67M | -19.09M |
| EBIT | -12.56M | -12.77M | -14.28M | -15.09M | -19.77M |
| EBITDA | -12.28M | -12.49M | -13.99M | -14.81M | -19.50M |
| EPS Basic | -11.24 | -13.89 | -18.01 | -21.05 | -28.23 |
| Normalized Basic EPS | -7.02 | -8.68 | -11.25 | -13.17 | -17.79 |
| EPS Diluted | -11.26 | -13.92 | -18.03 | -21.05 | -28.23 |
| Normalized Diluted EPS | -7.02 | -8.68 | -11.25 | -13.17 | -17.79 |
| Average Basic Shares Outstanding | 65.80M | 56.12M | 46.07M | 39.63M | 38.21M |
| Average Diluted Shares Outstanding | 65.80M | 56.12M | 46.07M | 39.63M | 38.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |